临床荟萃

• 论著 • 上一篇    下一篇

深圳市幽门螺杆菌耐药特点多中心研究

  

  1. 1.香港大学深圳医院 消化及肝脏科,广东 深圳 518053;2.香港玛丽医院 消化及肝脏科,中国 香港;
    3.深圳市第二人民医院 消化内科,广东 深圳 518035;4.深圳市宝安区人民医院 消化内科,广东 深圳 518101;
    5.深圳市人民医院龙华分院 消化内科,广东 深圳 518109;6.深圳市罗湖区人民医院 消化内科,广东 深圳 518001
  • 出版日期:2020-08-20 发布日期:2020-06-24
  • 通讯作者: 吕涛,Email: lvt@hkuszh.org
  • 基金资助:
    深圳市科技创新委员会基础研究计划---难治性幽门螺杆菌感染与临床药物干预及高通量测序技术的关联性多中心研究(JCYJ20160429190841946)

A multicenter study of antibiotic resistance characteristics of Helicobacter pylori in Shenzhen

  1. 1.Department  of Gastroenterology and Hepatology,  the University of HongkongShenzhen Hospital, 
    Shenzhen 518053,  China; 2.Department of Gastroenterology and Hepatology,  Queen Mary  Hospital, 
    Hongkong,  China; 3.Department of Gastroenterology,  the Second People's Hospital of Shenzhen,
    Shenzhen 518035,  China; 4.Department of Gastroenterology, Baoan People's Hospital, Shenzhen 518101,  China;
    5.Department of Gastroenterology, Longhua Branch of Shenzhen People's Hospital, Shenzhen 518109,  China;
    6.Department of Gastroenterology,  Luohu People's Hospital, Shenzhen 518001,  China
  • Online:2020-08-20 Published:2020-06-24
  • Contact: Corresponding author: Lu Tao, Email: lvt@hkuszh.org

摘要: 目的  分析深圳市幽门螺杆菌(Helicobacter pylori,  H.pylori)抗生素耐药特点,以及药敏结果指导下H.pylori根治率情况。方法  深圳多中心2017年1月至2018年12月募集碳13尿素呼气试验(13C urea breath test,  13CUBT)阳性初治、胃镜检查患者,行H.pylori培养及药敏试验分析耐药特点,并依据药敏结果根治H.pylori,分析药敏结果及耐药背景指导下H.pylori根治率。结果  2017年1月至2018年12月共完成H.pylori培养688例,培养阳性率76.9%,药敏试验结果显示抗生素耐药率分别为阿莫西林1.3%,克拉霉素34.0%,左氧氟沙星40.5%,甲硝唑90.4%,痢特灵、盐酸四环素暂未见耐药,联合耐药率56.1%。培养阳性患者依据药敏结果根治率达94.4%,培养阴性患者依据耐药背景根治率为85.4%。结论  深圳地区H.pylori联合耐药率已高于55%。阿莫西林、呋喃唑酮、四环素耐药率低,克拉霉素、左氧氟沙星耐药率较高,且左氧氟沙星耐药率已高于克拉霉素。依据药敏结果及本地抗生素耐药背景,可有效提高H.pylori根治率。

关键词: 幽门螺杆菌, 细菌培养, 耐药, 多中心研究

Abstract: Objective   To analyze the antibiotic resistance characteristics of  Helicobacter pylori(H.pylori) in Shenzhen,  and the eradication rate of it  based on the results of antibiotic resistance. Methods   Patients undergoing gastroscopy with initial treatment of  13C  urea breath test (13CUBT) positive in Shenzhen from January 2017 to December 2018 were collected. H.pylori culture and antimicrobial susceptibility testing  were carried out to analyze the antibiotic resistance characteristics. H.pyloriwas cured according to the drug susceptibility. The eradication rate of H.pyloribased on the antimicrobial susceptibility testing and resistance background  was analyzed.Results   A total of 688 H.pyloricultures were completed from January 2017 to December 2018,  and the positive rate of culture was 76.9%. The antimicrobial susceptibility testing showed the antibiotic resistance rates: 1.3% for amoxicillin,  34.0% for clarithromycin,  40.5% for levofloxacin,  and 90.4% for metronidazole. No resistance was observed for furazolidone and tetracycline hydrochloride. The resistance rate for multiple antibiotics was 56.1%. The eradication rate of patients with positive culture was 94.4% based on the results of antimicrobial susceptibility testing,  and that  of patients with negative culture was 85.4% according to the resistance background. Conclusion   Shenzhen sees  that the multiple antibiotics resistance rate for H.pyloriwas higher than 55%. The resistance rate of amoxicillin,  furazolidone and tetracycline was low,  and that of clarithromycin and  levofloxacin was relatively higher. And levofloxacin  had a higher resistance rate than clarithromycin. The eradication rate for H.pylori could be improved  according to the results of antimicrobial susceptibility testing and  the local antibiotic resistance background.

Key words: Helicobacter pylori, bacterial culture, antibiotic resistance, multicenter study